Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease.

Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease.

Biomarkers useful for diagnosis and evaluation of treatment for patients with Fabry disease are urgently needed. Recently, plasma globotriaosylsphingosine (lyso-Gb3) and lyso-Gb3-related analogues have attracted attention as promising biomarkers of Fabry disease. However, the plasma concentrations o...

Full description

Bibliographic Details
Main Authors:	Hideaki Sueoka, Junji Ichihara, Takahiro Tsukimura, Tadayasu Togawa, Hitoshi Sakuraba
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4428877?pdf=render

Similar Items

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
by: Hideaki Sueoka, et al.
Published: (2015-01-01)

Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease
by: Tomoko Shiga, et al.
Published: (2021-12-01)

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
by: Takahiro Tsukimura, et al.
Published: (2021-09-01)

Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy
by: Takahiro Tsukimura, et al.
Published: (2020-12-01)

Cell Transplantation Combined with Recombinant Collagen Peptides for the Treatment of Fabry Disease
by: Daisuke Kami, et al.
Published: (2020-12-01)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
by: Giovanni Duro, et al.
Published: (2018-11-01)

Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patients.
by: Brandy Young-Gqamana, et al.
Published: (2013-01-01)

Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
by: Takahiro Tsukimura, et al.
Published: (2014-01-01)

Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
by: Takashi Kodama, et al.
Published: (2011-01-01)

Fabry disease in a Japanese population-molecular and biochemical characteristics
by: Hitoshi Sakuraba, et al.
Published: (2018-12-01)

LC-MS lipidomics of renal biopsies for the diagnosis of Fabry disease
by: Bazargani, S.F, et al.
Published: (2021)

Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor
by: Minori Kanzaki, et al.
Published: (2020-12-01)

LC-MS/MS Quantification of Tramadol and Gabapentin Utilizing Solid Phase Extraction
by: Pappula Nagaraju, et al.
Published: (2018-01-01)

Modern Approaches in the Identification and Quantification of Immunogenic Peptides in Cereals by LC-MS/MS
by: Thais O. Alves, et al.
Published: (2019-11-01)

Discrimination and classification of tobacco wastes by identification and quantification of polyphenols with LC–MS/MS
by: JUN WANG, et al.
Published: (2010-07-01)

Fast and Simple LC-MS/MS Method for Rifampicin Quantification in Human Plasma
by: Žane Temova Rakuša, et al.
Published: (2019-01-01)

Relative Quantification of Potential Biomarkers of HCV-related Diseases by LC-MS/MS
by: Tsung-Chi Hu, et al.
Published: (2012)

Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma
by: Aurélien Millet, et al.
Published: (2021-03-01)

Lyso-Gb3 Increases αvβ3 Integrin Gene Expression in Cultured Human Podocytes in Fabry Nephropathy
by: Hernán Trimarchi, et al.
Published: (2020-11-01)

Rapid Analysis of Aristolochic Acid Analogues in Traditional Chinese Patent Medicine by LC-MS/MS
by: Jing Liu, et al.
Published: (2020-01-01)

Identification and Quantification of Enniatins and Beauvericin in Animal Feeds and Their Ingredients by LC-QTRAP/MS/MS
by: Josefa Tolosa, et al.
Published: (2019-02-01)

Validated LC-MS/MS Method for the Quantification of Ponatinib in Plasma: Application to Metabolic Stability.
by: Adnan A Kadi, et al.
Published: (2016-01-01)

Simultaneous LC/MS/MS quantification of eight apolipoproteins in normal and hypercholesterolemic mouse plasma[S]
by: Richard Wagner, et al.
Published: (2019-04-01)

Quantification of tolvaptan in rabbit plasma by LC–MS/MS: Application to a pharmacokinetic study
by: Kumar S. Moola, et al.
Published: (2015-12-01)

Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses
by: Galina Baydakova, et al.
Published: (2020-03-01)

Targeted Metabolomics: The LC-MS/MS Based Quantification of the Metabolites Involved in the Methylation Biochemical Pathways
by: Georgia Ntasi, et al.
Published: (2021-06-01)

Effect of Sample Preparation on the Detection and Quantification of Selected Nuts Allergenic Proteins by LC-MS/MS
by: Sorel Tchewonpi Sagu, et al.
Published: (2021-08-01)

LC-MS/MS Quantification of Nevirapine and Its Metabolites in Hair for Assessing Long-Term Adherence
by: Haoran Yang, et al.
Published: (2020-12-01)

Detection of cathinone and mephedrone in plasma by LC-MS/MS using standard addition quantification technique
by: Shu-Yuan Cheng, et al.
Published: (2017-09-01)

Ultra-fast Generic LC-MS/MS Method for High-Throughput Quantification in Drug Discovery
by: So-Hee Kim, et al.
Published: (2013-09-01)

Comparative profiling and comprehensive quantification of stratum corneum ceramides in humans and mice by LC/MS/MS[S]
by: Momoko Kawana, et al.
Published: (2020-06-01)

A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid
by: Rohini Sidhu, et al.
Published: (2015-06-01)

Rapid quantification of free and esterified phytosterols in human serum using APPI-LC-MS/MS
by: Jan Lembcke, et al.
Published: (2005-01-01)

Quantification of desloratadine in human plasma by LC-ESI-MS/MS and application to a pharmacokinetic study
by: Venkata Suresh Ponnuru, et al.
Published: (2012-06-01)

Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review
by: Hironobu Fujisawa, et al.
Published: (2019-12-01)

Proteomic Analysis of stem cells with NanoLC-ESI MS/MS
by: Cheng, Ting-Fu, et al.
Published: (2010)

RIPK3 Contributes to Lyso-Gb3-Induced Podocyte Death
by: So-Young Kim, et al.
Published: (2021-01-01)

Studies of nucleobases, nucleosides and nucleotides by LC, CZE, LC-MS, CZE-MS and MS techniques
by: Gong, H.
Published: (2000)

Treatment Efficiency in Gaucher Patients Can Reliably Be Monitored by Quantification of Lyso-Gb1 Concentrations in Dried Blood Spots
by: Claudia Cozma, et al.
Published: (2020-06-01)

Trace Level Detection of Bisphenol A Analogues and Parabens by LC-MS/MS in Human Plasma from Malaysians
by: Idha Arfianti Wiraagni, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_h5putjqq1tq1dbnqvpk223uqlo